版本:
中国

BRIEF-Mylan signs sub-license agreement with the Medicines Patent Pool to produce and market DAKLINZA tablets to 112 countries

Nov 28 Mylan NV :

* Mylan signs sub-license agreement with the Medicines Patent Pool to increase access to Hepatitis C treatment in developing countries

* Agreement licenses Co to produce and market generic version of Bristol-Myers Squibb's DAKLINZA tablets, 30 mg and 60 mg to 112 countries Source text for Eikon: Further company coverage:

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐